 |
 |
 |
 |
 |
|
|
| Article 1 to 4 out of 4 concerning Pfizer Inc.
|
-
Accelrys Announces Pfizer Inc. as the First Member of the Enterprise Cheminformatics Consortium
(05 Feb 2007)
Consortium to Drive the Evolution of Enterprise Cheminformatics Systems Using Open and Flexible Service-Oriented Architecture
Accelrys, Inc. announced the addition of Pfizer to the Accelrys Enterprise Cheminformatics Consortium. The Consortium will be a collaborative software development project led by Accelrys in partnership with a group of commercial member ...
-
Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics
(11 Jan 2007)
Archemix Corp. announced that it has signed an agreement with Pfizer focused on the discovery of first-in-class aptamers for the development and commercialization as therapeutics. As part of the collaboration, Archemix will use its proprietary SELEX ...
-
Out of REACH
(21 Nov 2006)
New legislation threatens medicines
Europe's proposed new chemicals legislation, REACH, could disrupt the supply of important medicines. David Vosvenieks, REACH issue manager at AstraZeneca (AZ), told Chemistry & Industry that two companies supplying intermediates required for two AZ ...
-
Tepnel signs Quality Agreement with Pfizer Ltd for CGMP Services
(25 Jul 2006)
Tepnel Life Sciences PLC, a UK-based international Molecular Diagnostics and Research Products & Services group, announced that it's Scottish pharmaceutical services subsidiary, Tepnel Scientific Services Ltd, has entered into a quality agreement ...
 |
|
|
|
|